Pharmaceutical industry in China

Chinese pharmaceutical industrypharmaceuticalsChinese marketList of pharmaceutical companies in Chinamodern pharmaceutical industriespharmaceutical industry
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.wikipedia
201 Related Articles

National Medical Products Administration

State Food and Drug AdministrationChina Food and Drug AdministrationCFDA
Since June 30, 2004, the State Food and Drug Administration (SFDA) has been closing down manufacturers that do not meet the new GMP standards.

Shijiazhuang Pharma Group

CSPC Pharmaceutical GroupChina Pharmaceutical Group LtdCSPC Pharmaceutical Group Ltd
*Pharmaceutical industry in China

Sinopharm Group

In terms of sales, China's top three companies: Sinopharm Group, Shanghai Pharmaceutical Co. and Jiuzhoutong Group Corp., are all shared less than 5% of the national market.
*Pharmaceutical industry in China

China

People's Republic of ChinaChineseCHN
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.

Pharmaceutics

pharmaceutical technologypharmaceuticalpharmaceutical technologists
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery.

Drug

drugsagentserum
China accounts for 20% of the world's population but only 1.5% of the global drug market.

Healthcare reform in China

Healthcare system reform in the People's Republic of Chinachanging health-care environmentCooperative Medical Scheme
China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services.

Health insurance

medical insurancehealthhealth benefits
China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services.

Therapy

therapeutictherapisttreatment
The most often-cited adverse factors in the marketplace include a lack of protection of intellectual property rights, a lack of visibility for drug approval procedures, a lack of effective governmental oversight, poor corporate support for drug research, and differences in the treatment in China that are accorded to local and foreign firms.

Novartis

SandozCiba-GeigyHexal Australia
Most notably, Novartis is expected to establish a large Research and development base in Shanghai that will be a pillar of its drug development.

Shanghai

Shanghai, ChinaSHAShanghai Municipality
Most notably, Novartis is expected to establish a large Research and development base in Shanghai that will be a pillar of its drug development.

Prescription drug

prescriptionprescription drugsprescription medication
China is the world's second-largest prescription drug market, according to a report released by pharmaceutical market research firm IMS Health.

IMS Health

IMSIMS Health Inc.
China is the world's second-largest prescription drug market, according to a report released by pharmaceutical market research firm IMS Health.

Ministry of Industry and Information Technology

Ministry of Information IndustryMinistry of Industry and Information Technology of the People's Republic of ChinaMinister of Industry and Information Technology
The value-added output of China's pharmaceutical industry increased 14.9% year on year in 2009, according to statistics released by the Ministry of Industry and Information Technology.

Demand

consumer demandmarket demanddemand side
Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals, the lower labor costs and the changes resulting from economic reform.

Medication

pharmaceuticalpharmaceuticalspharmaceutical drug
Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals, the lower labor costs and the changes resulting from economic reform.

Labour economics

laborlabor economicslabor market
Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals, the lower labor costs and the changes resulting from economic reform.

Chinese economic reform

reform and openingeconomic reformsreform and opening up
Investment conditions in China have improved due to the vast consumer demand for pharmaceuticals, the lower labor costs and the changes resulting from economic reform.

TRIPS Agreement

Agreement on Trade-Related Aspects of Intellectual Property RightsTRIPSTrade-Related Aspects of Intellectual Property Rights
Changes to the patenting laws in full compliance with the requirement of the Agreement on Trade-Related Aspects of Intellectual Property Rights (or "TRIPS Agreement") and the lack of Chinese pharmaceutical R&D have also left gaps in the market.

List of companies of China

List of Chinese companiesChinese companiesList of companies of the People's Republic of China
But sales at the top-tier Chinese companies are growing faster than at Western ones, according to IMS Health Inc.

Hospital

hospitalsinfirmarygeneral hospital
Even the top selling companies just barely exceed sales of $100 million (hospital market).

Over-the-counter drug

over-the-counterover the counterOTC
In addition, China's over-the-counter market is growing fast and has become the fourth largest OTC market in the world.